Some 86.6% of 308 breast cancer patients surveyed said they had heard a little about the Government’s screening pilot but did not understand it, or had never heard of it, according to the Global Chinese Breast Cancer Organizations Alliance.

The Alliance surveyed the patients from May to August 2026. It found that 5.5% had wanted to take part in the pilot; the vast majority of that group said they had been rejected.

Nearly six in ten respondents said medical staff had not explained the difference between 2D and 3D mammography. 70% had insufficient knowledge of 3D mammography. 90% said they would pay the price difference to choose it, and 96% supported increased government subsidies.

The Alliance is calling for the pilot to cover medium- and average-risk people, for more publicity and for greater subsidies for 3D screening, with 3D screening included in regular subsidies. It also wants more transparent information. A doctor cited in the report said the pilot’s high-risk definition includes people with a family history, while more than 80% of breast cancer patients are not classed as high risk.

The Department of Health said the pilot’s second phase, for high-risk women, began in June 2025 and has no co-payment. It also said a free online breast cancer risk-assessment tool provides prevention and screening advice, and that all breast cancer cases detected under the pilot by 30 June 2026 were stage I or earlier.